Form 6-K ASTRAZENECA PLC For: Nov 09

Go back to Form 6-K ASTRAZENECA PLC For: Nov 09

AstraZeneca (AZN) Tops Q3 EPS by 6c

November 10, 2016 8:27 AM EST

AstraZeneca (NYSE: AZN) reported Q3 EPS of $0.80, $0.06 better than the analyst estimate of $0.74. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.95 billion.

Pascal Soriot, Chief Executive Officer, commenting on the results said:

The performance in the third quarter was in line with our expectations,... More